Mode of progression in smoldering multiple myeloma: a study of 406 patients
Blood Cancer Journal, Published online: 17 January 2024; doi:10.1038/s41408-024-00980-5Mode of progression in smoldering multiple myeloma: a study of 406 patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 17, 2024 Category: Hematology Authors: Nadine H. Abdallah Arjun Lakshman Shaji K. Kumar Joselle Cook Moritz Binder Prashant Kapoor Angela Dispenzieri Morie A. Gertz Martha Q. Lacy Suzanne R. Hayman Francis K. Buadi David Dingli Yi Lin Taxiarchis Kourelis Rahma Warsame Leif Bergsagel S. Vincent Source Type: research
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
Blood Cancer Journal, Published online: 16 January 2024; doi:10.1038/s41408-024-00978-zTranslocation t(14;16) in multiple myeloma: gangster or just part of the gang? (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 16, 2024 Category: Hematology Authors: Hira Mian Martin Kaiser Rafael Fonseca Source Type: research
Time independent factors that predict relapse in adults with acute myeloid leukemia
Blood Cancer Journal, Published online: 15 January 2024; doi:10.1038/s41408-023-00954-zTime independent factors that predict relapse in adults with acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 15, 2024 Category: Hematology Authors: John J. Lim Megan Othus Carole M. Shaw Kathryn Russell Anna B. Halpern Jacob S. Appelbaum Paul Hendrie Roland B. Walter Elihu H. Estey Mary-Elizabeth M. Percival Source Type: research
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk
Blood Cancer Journal, Published online: 15 January 2024; doi:10.1038/s41408-023-00974-9Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 15, 2024 Category: Hematology Authors: Ashwin Kishtagari M. A. Wasay Khan Yajing Li Caitlyn Vlasschaert Naimisha Marneni Alexander J. Silver Kelly von Beck Travis Spaulding Shannon Stockton Christina Snider Andrew Sochacki Dixon Dorand Taralynn M. Mack P. Brent Ferrell Jr Yaomin Xu Cosmin A. B Source Type: research
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Blood Cancer Journal, Published online: 10 January 2024; doi:10.1038/s41408-023-00973-wOutcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 10, 2024 Category: Hematology Authors: Oren Pasvolsky Sassine Ghanem Den ái R. Milton Mikael Rauf Mark R. Tanner Qaiser Bashir Samer Srour Neeraj Saini Paul Lin Jeremy Ramdial Yago Nieto Guilin Tang Yosra Aljawai Hina N. Khan Partow Kebriaei Hans C. Lee Krina K. Patel Sheeba K. Thomas Donna M Source Type: research
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms
Blood Cancer Journal, Published online: 04 January 2024; doi:10.1038/s41408-023-00969-6Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 4, 2024 Category: Hematology Authors: Panhong Gou Duanya Liu Saravanan Ganesan Evelyne Lauret Nabih Maslah Veronique Parietti Wenchao Zhang V éronique Meignin Jean-Jacques Kiladjian Bruno Cassinat Stephane Giraudier Source Type: research
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma
Blood Cancer Journal, Published online: 04 January 2024; doi:10.1038/s41408-023-00971-yA MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 4, 2024 Category: Hematology Authors: A. V. de Jonge J. A. A. Bult D. F. E. Karssing M. Nijland M. E. D. Chamuleau M. Brink Source Type: research
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
Blood Cancer Journal, Published online: 04 January 2024; doi:10.1038/s41408-023-00970-zTreatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 4, 2024 Category: Hematology Authors: Elise R. A. Pennings M üjde Durmaz Otto Visser Eduardus F. M. Posthuma Djamila E. Issa Martine E. D. Chamuleau Pieternella J. Lugtenburg Marie Jos é Kersten Avinash G. Dinmohamed Source Type: research
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia
Blood Cancer Journal, Published online: 21 December 2023; doi:10.1038/s41408-023-00964-xSociodemographic associations with uptake of novel therapies for acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 21, 2023 Category: Hematology Authors: Andrew Hantel Colin Cernik Hajime Uno Thomas P. Walsh Gregory S. Calip Daniel J. DeAngelo Christopher S. Lathan Gregory A. Abel Source Type: research
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
Blood Cancer Journal, Published online: 21 December 2023; doi:10.1038/s41408-023-00959-8Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse? (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 21, 2023 Category: Hematology Authors: Carlotta Giupponi Diego Bertoli Erika Borlenghi Chiara Cattaneo Tatiana Zollner Lorenzo Masina Samuele Bagnasco Elisa Cerqui Francesca Federico Chiara Pagani Silvana Archetti Duilio Brugnoni Giuseppe Rossi Alessandra Tucci Source Type: research
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M
Blood Cancer Journal, Published online: 21 December 2023; doi:10.1038/s41408-023-00965-wLymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 21, 2023 Category: Hematology Authors: David Fandrei Tony Huynh Marie S ébert Lorea Aguinaga Valeria Bisio Rathana Kim Emmanuelle Clappier Marion Esp éli Karl Balabanian H élène Moins-Teisserenc Antoine Toubert Nicolas Dulphy Pierre Fenaux Lionel Ad ès Lin-Pierre Zhao Source Type: research
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Blood Cancer Journal, Published online: 20 December 2023; doi:10.1038/s41408-023-00963-yProphylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 20, 2023 Category: Hematology Authors: Sara A. Scott Ellen M. Marin Kathryn T. Maples Nisha S. Joseph Craig C. Hofmeister Vikas A. Gupta Madhav V. Dhodapkar Jonathan L. Kaufman Sagar Lonial Ajay K. Nooka Source Type: research
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis
Blood Cancer Journal, Published online: 19 December 2023; doi:10.1038/s41408-023-00967-8Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 19, 2023 Category: Hematology Authors: Marie-France Gagnon Alan R. Penheiter Faye Harris Dorsay Sadeghian Sarah H. Johnson Giannoula Karagouga Alexa McCune Cinthya Zepeda-Mendoza Patricia T. Greipp Xinjie Xu Rhett P. Ketterling Ellen D. McPhail Rebecca L. King Jess F. Peterson George Vasmatzis Source Type: research
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia
Blood Cancer Journal, Published online: 18 December 2023; doi:10.1038/s41408-023-00962-zTargeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 18, 2023 Category: Hematology Authors: Rong Fan Hatice Satilmis Niels Vandewalle Emma Verheye Elke De Bruyne Eline Menu Nathan De Beule Ann De Becker Gamze Ates Ann Massie Tessa Kerre Marie T örngren Helena Eriksson Karin Vanderkerken Karine Breckpot Ken Maes Kim De Veirman Source Type: research
Addressing the disparities: the approach to the African American patient with multiple myeloma
Blood Cancer Journal, Published online: 18 December 2023; doi:10.1038/s41408-023-00961-0Addressing the disparities: the approach to the African American patient with multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 18, 2023 Category: Hematology Authors: Manisha Bhutani Brandon J. Blue Craig Cole Ashraf Z. Badros Saad Z. Usmani Ajay K. Nooka Leon Bernal-Mizrachi Joseph Mikhael Source Type: research
